Diener, Hans Christoph http://orcid.org/0000-0002-6556-8612
May, Arne
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Accepted: 27 November 2021
First Online: 17 December 2021
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL.
: HCD received honoraria for participation in clinical trials, contribution to advisory boards, or oral presentations from: Ipsen, Lilly, Lundbeck, Novartis, Pfizer, and Teva. The German Research Council (DFG), the German Ministry of Education and Research (BMBF), and the European Union support his headache research. HCD serves on the editorial boards of <i>Cephalalgia</i>, <i>Drugs</i>, and <i>Lancet Neurology</i>. HCD is a member of the Clinical Trials Committee of the IHS. AM is the editor of <i>Cephalalgia</i> and reports no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: HCD and AM contributed equally to the review. HCD and AM approved the final version of the manuscript and agree to be accountable for the work presented.